A B S T R A C T Platelet-activating factor (PAF) is liberated from antigen-stimulated, IgE-sensitized rabbit basophils and induces aggregation of platelets and secretion of their content of vasoactive amines. Experiments were performed to determine the relationship between these two platelet responses to this stimulus.
INTRODUCTION
Platelet-activating factor (PAF)l is a soluble molecule which is secreted from IgE-sensitized rabbit basophils upon interaction with specific antigen. It is the active principle of a cooperative allergic reaction involving platelets and leukocytes first described by Barbaro and Zvaifler (1) . The reaction was shown to involve IgE antibody (2) , basophils (2) (3) (4) , and the release from leukocytes of a soluble factor (4) (5) (6) termed platelet-activating factor (2) . PAF has now been demonstrated in rats (7) and man (8) (9) (10) and appears to be a low molecular-weight lipid (7, 11) which binds to albumin (2) . The material acts on platelets to stimulate aggregation (2) and secretion of vasoactive amines (5) . In previous papers (12, 13) , we defined the PAF-induced release reaction, described the generation of a specific state of desensitization in the platelets, and indicated the involvement of serine proteases, the cyclic AMP system, and intracellular contractile elements in the secretory event.
Recent experiments (14) have shown that PAFinduced release and aggregation occur in vivo as well as in vitro. In fact, a pathogenetic role for this mediator has been suggested in the deposition of immune complexes in acute immune complex disease (15) , in the accumulation of platelets in immunologic skin lesions (16) , and more recently, in IgE anaphylaxis2 (14, 17, 18) . 1Abbreviations used in this paper: ALMe, acetyl lysine methyl ester; BAMe, benzoyl-l-arginine methyl ester; DFP, diisopropylphosphofluoridate; EGTA, ethylene glycol-bis (J3-aminoethyl ether) N,N,N',N'-tetraacetate; LMe, lysine methyl ester; PAF, platelet-activating factor; TAMe, tosyl-larginine methyl ester. 2 Henson, P. M., and R. N. Pinckard. Manuscripts submitted for publication.
Aggregation and release of constituents have been suggested by Holmsen (19) to represent different stages in a continuum of the platelet response to a stimulus. Agents which destroy or consume ADP have been used by a number of investigators to show that the aggregation induced by many stimuli, including collagen, or even thrombin, may result in part from the release of platelet ADP, which then causes the aggregation (20) (21) (22) (23) . In addition, the recent discovery of potent pharmacologic intermediates of the prostaglandin synthesis pathway, has suggested that these may represent the common platelet-activating material and that many stimuli activate by initiating prostaglandin synthesis (24) (25) (26) .
Accordingly, we considered it important to examine the interdependence of the aggregation and release reaction induced in rabbit platelets by basophilderived PAF. The question may be posed in three ways. (a) Is aggregation a consequence of the release, for example, of the aggregating-agent ADP? (b) Is aggregation required for the release reaction? (c) Are the two phenomena independent of each other, and if so, are they induced by the same activator? The experiments described herein are designed to address these queries.
METHODS
Animals. New Zealand white rabbits of either sex weighing from 2.5 to 4 kg were employed, as the source of platelets and PAF. Blood for platelets was not removed at intervals of < 1 mo.
Immunization. Horse radish peroxidase (type II, Sigma Chemical Co., St. Louis, Mo.) in saline was used as antigen. The initial injection comprised 10 mg in saline subcutaneously into 2.5-kg rabbits. Thereafter, animals were reimmunized with 5 mg/injection at variable intervals (1-6 mo) . The rabbits were bled for PAF production 7-10 days after each immunization.
Preparation of PAF. Blood was obtained from the central ear artery into 1/6 vol of acid citrate dextrose (27) . The procedure thereafter was similar to that described previously (2) . The blood was sedimented at 500g for 20 min at room temperature. The platelet-rich plasma was removed.
The buffy coat layer on top of the erythrocytes was harvested with a siliconized (Siliclad, Clay Adams, Div. of Becton, Dickinson & Co., Parsippany, N. J.) Pasteur pipette with tip bent at right angles. An equal volume of 2.5% gelatin in isotonic phosphate-buffered saline was added, and the mixture was incubated at 370C for 30 min to sediment most of the erythrocytes. The supernatant cell suspension was removed and centrifuged at 500 g for 15 min at room temperature. The cell pellet was resuspended in a small volume of Tris-buffered Tyrode's solution with no Ca++ or Mg++ and with ethylene glycol-bis (f8-aminoethyl ether)-N,N,N',N'-tetraacetate (EGTA). Remaining erythrocytes were removed by hypotonic lysis. For each 2 ml of cell suspension, 6 ml of distilled water was added, and after 30s, 2 ml of 3.5% saline was used to restore isotonicity. Platelets were removed by four to five washes (8 min at 180 g in the cold) in the 50-ml plastic tubes using Tris-buffered Tyrode's solution without Ca++ or Mg++. Cells were resuspended to 1 x 107 leukocytes/ml in Tris-Tyrode's with 0.25% bovine serum albumin. The cell concentration is important because if it is higher, the PAF apparently binds to the other cells present, and the yield is lowered. The albumin is essential and provides a carrier for the PAF (2). Antigen (50 Sg peroxidase for each 107 cells) was added and incubated for 20 min at 37°C. The cells were removed (500 g, for 10 min), and the supematant fluid containing PAF-albumin was tested, dialyzed against phosphate-buffered saline or Tris-buffered saline overnight at 4°C, and frozen in aliquots at -700C.
Extraction of PAF from albumin. PAF-albumin was added to a column of SM2 beads (Bio-Rad Laboratories, Richmond, Calif.) at room temperature, incubated 30 Preparation of platelets. Rabbit platelets were prepared as described previously (28) . Blood was taken into acid citrate dextrose (as for PAF production) and centrifuged at 500 g for 20 min. The entire preparation procedure was carried out at room temperature and with plastic containers and pipettes. The platelet-rich plasma was removed and incubated at 37°C with 0.6 ,uCi[3H]serotonin, binoxalate per ml (4.3 Ci/mmol, New England Nuclear, Boston, Mass.) for 15 min. The platelets were sedimented at 1,800 g for 15 min and washed first in Tyrode's-gelatin without Ca++ and with EGTA and then in Tyrode's-gelatin without Ca++. The platelets were resuspended in the latter buffer and diluted to 2.5 x 109/ml. For experiments they were diluted 1/10 in Tyrode'sgelatin containing calcium. The preparation procedure is modified from that of Ardlie et al. (29) and preserves the platelet Mg++. Such platelets are readily aggregated by ADP in micromolar concentrations and are still discoid in shape. These characteristics are both indicative of normality. The platelets were kept at room temperature and used within 3 or 4 h of preparation. While their reactivity to ADP declined somewhat over this time, that to PAF remained unaltered.
Platelet stimuli. Thrombin (bovine, Parke, Davis & Co., Detroit, Mich.) was diluted in Tyrode's-gelatin. Epinephrine (Parke, Davis & Co.) was also diluted in Tyrode's-gelatin, but only immediately before use. Collagen was prepared by homogenization and then sonification of bovine tendon collagen (Sigma Chemical Co.) in saline. Alternatively, it was purchased from Worthington Biochemical Corp., Freehold, N. J. (soluble calf skin collagen) and diluted in Tyrode's solution before use. ADP was obtained from Sigma Chemical Co., and was freshly dissolved before use.
Release of serotonin. The standard reaction mixture contained 0.1 ml of 2.5 x 109/ml platelets, varying amounts of PAF, and Tyrode's gelatin to 1 ml, yielding a final concentration of 2.5 x 108/ml platelets, previously found to be optimal for PAF (12 (31) . Lactic dehydrogenase and,S-glucuronidase were assayed as described previously (28) .
Platelet aggregation. The standard reaction mixture contained 0.05 ml of 2.5 x 109/ml platelets, varying amounts of stimulus, and Tyrode's-gelatin (containing calcium) to 0.5 ml. The Tyrode's was warmed to 37°C in the aggregation cuvette, the platelets and a Teflon-coated magnetic stirring rod was added, and the mixture was stirred at 1,100 rpm, at 37°C in an aggregometer (Chrono-Log Corp., Havertown, Pa.) for 2-3 min. Upon addition of the stimulus, the increase in light transmission was traced on a chart recorder. Aggregation was quantitated as described in the Results section.
Inhibitors. Diisopropylphosphofluoridate (DFP) was purchased from Sigma Chemical Co. and was dissolved in Tyrode's at 50 mM immediately before use. Amino acid esters came from Sigma Chemical Co., except for lysine methyl ester, which came from Cyclo Chemicals, Miami, Fla., and were also dissolved in Tyrode's solution. Apyrase was obtained from Sigma Chemical Co. and was dissolved in Tyrode's solution.
RESULTS

PAF-induced aggregation
Typical tracings of the aggregation of rabbit platelets, induced by PAF are depicted in Fig. 1 Is secretion required for aggregation? Dose response of stimuli. To investigate the relationship between PAF-induced aggregation and secretion, the effect of different concentrations of PAF on each of these parameters was examined (Fig. 2) . It was found that 50% of the maximal release of serotonin (measured in the supernate from platelets undergoing aggregation) required about seven times as much PAF as 50% of the maximal aggregation (measured by the extent or rate of aggregation). This was true for both albumin-bound and extracted PAF. This provided the first suggestion that the aggregation response was not wholly a consequence of the release reaction. The data contrast with those obtained for thrombin in that 50% of the maximal secretion and aggregation was obtained with equivalent concentrations (data not shown). The dose-response relationship of PAF-induced secretion can be seen in Fig. 2 . As described previously (12) , maximum secretion often represents release of only 50-70% of the available serotonin.
PAF-induced secretion of nucleotides. The data in Fig. 2 which induced minimal release of ADP, ATP, or serotonin. In these experiments, not enough detectable ADP was liberated or generated to have initiated the aggregation during the time period over which aggregation occurred (Table I) . The effect of creatine phosphate and creatine phosphokinase or of apyrase. To confirm the suggestion that ADP was not responsible for the PAF-induced aggregation, reagents which would consume or destroy any ADP which was released were employed (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . Fig. 3 shows the effect of creatine phosphate in the presence of creatine phosphokinase (22) . All released ADP is converted to ATP. The reagents completely prevented ADP aggregation (although not the shape change). They also markedly diminished the aggregation caused by collagen. However, no effect was seen on PAF-induced aggregation. It is important to note that the concentrations of PAF used were chosen to be submaximal so that any possible effect of the creatine phosphate and creatine phosphokinase could be most readily determined. Similarly, (although not shown) apyrase, at concentrations 10 times those capable of completely preventing ADP aggregation, were unable to reduce that caused by PAF.
Enhancement of PAF-induced aggregation by ADP. Packham et al. (23) have shown synergistic effects between ADP and other platelet stimuli. To address this possibility in the case of PAF, experiments were performed in which PAF-induced aggregation was examined immediately after the addition of low doses of ADP. A typical experiment is shown in Fig. 4 . In this experiment, ADP concentrations were chosen which were just below those required to give aggregation, although the shape change was still produced. Aggregation produced by low concentrations of PAF was enhanced by the ADP, though not to a great degree. If doses of ADP which just gave aggregation were used, the subsequent PAF response was again slightly enhanced, but not appreciably over the probable sum Fig. 6 , indicating that PAF induces aggregation in these circumstances even at low doses.
The effect of ADP on platelets desensitized to PAF. To determine whether PAF aggregation would render platelets refractory to an ADP effect, ADP was added to platelets which had previously responded to PAF (aggregation and deaggregation). A normal effect of ADP was seen (Fig. 5 ).
We had previously described the induction of a state of specific desensitization in rabbit platelets to the induction of the release reaction by PAF (12) .
Experiments were performed to determine whether such a desensitized state could be induced to PAFinduced aggregation and whether the desensitized platelets were still responsive to ADP. Accordingly, The ADP concentration, which involved only a shape change and was still higher than the concentration detected in the medium after PAF had induced maximal platelet aggregation (Table I) (Fig. 7) . (Fig. 8) . This release of serotonin (25.1) is less than that seen with stirring (35.6), but inasmuch as 5pu PAF SO* w there is no mixing of PAF with the platelet suspension in the absence of stirring, this difference would be expected. By pouring platelet suspensions made refractory (0.5 ml) into 2 ml glutaraldehyde (0.2% final conrnse of washed centration) followed by microscope examination, it cted at the top. was determined that <5% of the platelets was adteghatint slets herent to each other at the point of sampling (2 min), ve to PAF. (C) whereas 25% of the serotonin had been released. ;till aggregated With stirring, the release was increased to 35%, but most of the platelets were seen to be aggregated. The data from this and three other experiments sug-PAF-induced gest strongly that strong platelet-platelet binding is not Lts (incubated required for PAF-induced release of serotonin. actory to ADP [y the PAF-de-Inhibition by DFP and amino acid esters release seroan, thrombin,
We have previously postulated the requirement for in reference activation of a DFP-inhibitable serine protease in PAFier were also induced secretion (13, 32) . If the same PAF-receptor interaction can lead to both aggregation and secretion, DFP might be expected to inhibit both phenomena in a similar fashion. Data presented in Fig. 9 show this to be the case. 50% inhibition of both responses Control was obtained with 50 mM DFP. It was further PAF-des .; determined that pretreatment of platelets or PAF with the inhibitor (which acts on serine proteases 501 ADPoorosp ADP (joN) 10 FIGURE 6 Aggregation of platelets rendered unresponsive (unresp) to ADP or desensitized (des) to PAF. 3-ml platelets (2.5 x 109/ml) were incubated with 5 mM EGTA (control), EGTA and 1.5 ml PAF (PAF-des), or EGTA and 100 mM ADP (ADP-unresp) for 20 min at 37°C. After incubation or, in the case of PAF desensitization, after incubation and washing, they were tested for aggregation induced by PAF or ADP. The ordinate represents units of aggregation (see Figs. 1 and 2 ). in an irreversible manner) followed by washing or dialysis, did not prevent the effects of their subsequent interaction. The activation of a precursor serine protease(s) is suggested.
As previously reported (13), low molecular weight amino acid esters inhibit PAF-induced secretion, presumably by acting on the putative activable serine protease. The data presented in Table II show the identical specificity of inhibition and degree of inhibition of aggregation as of secretion. Lysine methyl ester (LMe) is inhibitory, but the acetylated derivative (ALMe) is not. Similarly, tosyl-l-arginine methyl ester (TAMe) is inhibitory, but benzoyl-l-arginine methyl ester (BAMe) is not. These differences between LMe and ALMe or between TAMe and BAMe were not observed with collagen-or thrombin-induced platelet release reactions.3 DISCUSSION PAF stimulates platelet secretion, i.e. the 'release reaction' of Grette (32) and also platelet aggregation. The data presented herein indicate that these are two separable responses of the platelet to PAF and are not necessarily interdependent.
PAF-induced aggregation. Incubation of PAF with platelets under conditions of stirring or agitation results in a rapid shape change and then aggregation in a manner similar to that seen with other platelet stimuli. The platelets remain aggregated, however, for only a short period and then undergo spontaneous disaggregation. The aggregation is temperature-dependent, requires calcium (2) , and is inhibitable by DFP and certain amino-acid esters.
Experiments in which PAF extracted from the albumin (to which it is usually bound during preparation) were compared to albumin-bound PAF revealed no significant qualitative differences between the two species with regard to aggregation and release.
The characteristics of the aggregating effects of PAF are similar to those of PAF-induced release (12, 13) . In addition, DFP was found to inhibit both aggregation and release at the same concentration and also in the same manner. Furthermore, an identical (12) were here shown to exhibit reduced responsiveness to the aggregating action of PAF, although they were normally responsive to ADP. In contrast, ADP-refractory platelets reacted normally to PAF. The greater effect of desensitization on secretion than on aggregation may reflect the requirement for higher PAF concentration for the former effect.
Aggregation does not require the release reaction. Evidence has been presented that release of ADP (or other material) from platelets stimulated by PAF is not the primary cause of the aggregation. This has been contrasted with the effects of collagen. (a) As described above, platelets which were completely refractory to the aggregation induced by ADP were normally responsive to PAF. (b) Up to seven times more PAF was required to induce release than to initiate aggregation, and almost maximal aggregation was seen with doses of PAF which did not induce release of serotonin. This difference was seen with albuminbound as well as with extracted PAF and was additionally evident when the release and aggregation were both performed in the same cuvette under conditions of stirring at 1,100 rpm. increased aggregation response when added after PAF had already stimulated aggregation (Fig. 5) .
The experiments suggested strongly that PAFinduced aggregation is not solely a consequence of the release of ADP. It is also of interest that, in our work, PAF induces an aggregation of washed rabbit platelets which consistently is shorter-lived and disaggregates more readily than any other stimulus so far examined. The combined data suggest that the aggregation is not a consequence of the secretory process.
Aggregation is not required for secretion. The experiments also suggest that PAF induces the release reaction by a mechanism which is independent of the aggregation. Incubation of platelets with PAF in the complete absence of stirring or agitation eliminated aggregation but did not abolish secretion. Microscope examination of rapidly fixed platelet suispensions confirmed the lack of aggregation. The lower levels of release observed in the nonstirred situation almost certainly reflect the insufficient mixing inherent in this experimental design. Aggregation of platelets seems, therefore, not to be involved in PAFinduced secretion. While this is certainly true for firmly adhering aggregates of more than two platelets, the conclusion cannot be taken to its limit, because it cannot be shown that transient platelet-platelet interactions may not be involved.
Conclusions. The activation of rabbit platelets by PAF, as with other stimuli, leads to rapid aggregation and secretion. It is suggested that the interaction of PAF with its platelet receptor directly or indirectly activates a unique precursor serine protease. This can then stimulate, in order, pathways leading to both aggregation and secretion (see also 12, 21, 34) . Since both require energy and Ca++ and probably involve cyclic AMP and intracellular contractile elements (12, 34) , some portions of these pathways may be identical. Nevertheless, neither platelet response is dependent upon the other, and in fact, it may be possible to activate one without the other. It is, of course, possible that both aggregation and secretion are manifestations of the same overall cell response to PAF stimulation, because in this system, as is also true with other stimuli, clear-cut evidence of complete inhibition of one without the other has not yet been obtained.
Holmsen (19) has proposed that shape changes, aggregation, secretion of serotonin and nucleotides, and finally secretion of lysosomal enzymes represent four sequential stages in an overall response of platelets to a stimulus. Weaker stimuli initiate only the earlier stages. This concept of similar pathways involving Ca++ and contractile elements (actomyosin) for each type of platelet response is compatible with the information obtained for PAF (12, 13) and is similar to our hypothesized mechanistic similarity between responses to stimuli in a wide variety of cells, including platelets (34) . However, there may be separable processes involved in aggregation and secretion which could, on the one hand, involve largely common intracellular pathways, diverging only in the final cell reaction, or, alternatively, largely independent pathways utilizing similar intracellular elements.
